{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:38:00Z","timestamp":1794310680237,"version":"4.9.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Vancomycin is a core drug for the treatment of methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      , but its neurologic adverse effects are rarely reported. This case is the first to report a possible association between intravenous vancomycin and episodic migraine. Rapid identification of drug-induced migraine can avoid unnecessary invasive testing and medication delays and has direct clinical value.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To report and document a case of episodic migraine that was highly correlated with the timing of intravenous vancomycin administration, assessing causality and its general clinical significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This narrative case report is accompanied by an assessment of drug causality and supplemented by a review of pharmacovigilance databases. A systematic search using keywords was conducted. Inclusion criteria included case, cohort, or pharmacovigilance data related to headache\/migraine use with glycopeptide drugs. Primary headaches unrelated to the drug were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case:<\/jats:title>\n                    <jats:p>A 54-year-old woman was admitted to the hospital with traumatic injuries resulting in bilateral lower extremity pain and a 1-hour bleeding episode on the left leg. The injuries included multiple fractures and traumatic injuries, and a postoperative wound infection developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Based on wound culture results, the patient was treated with intravenous vancomycin. During intravenous vancomycin treatment, the patient developed episodic migraines, and a causal relationship to vancomycin was confirmed using the Naranjo score. After discontinuation of vancomycin, the patient\u2019s episodic migraines gradually resolved. The patient\u2019s episodic migraines resolved completely within 3 days, and the same symptoms did not recur during subsequent treatment. The patient remained headache-free for 3 months after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Pharmacovigilance data indicate that headaches associated with intravenous administration are rare but do occur with glycopeptide drugs. This review suggests that vancomycin may induce episodic migraines, a rare adverse effect that should be included in the differential diagnosis of acute headaches associated with intravenous glycopeptide drugs. Pharmacovigilance combined with therapeutic drug monitoring may serve as a low-cost, reproducible clinical identification tool. This case suggests a possible association between vancomycin and episodic migraines but does not directly prove causation, and further research is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046545","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:27Z","timestamp":1768849347000},"page":"e46545","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Paroxysmal migraine associated with vancomycin administration: A case report, a review of pharmacovigilance databases for similar cases and possible mechanisms"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8646-8645","authenticated-orcid":false,"given":"Jingjing","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Hefei BOE Hospital, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hefei BOE Hospital, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyi","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Hefei BOE Hospital, Hefei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Hefei BOE Hospital, Hefei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0025-6196(12)65799-1","article-title":"Vancomycin.","volume":"66","author":"Wilhelm","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R3-20260119","first-page":"39","article-title":"Literature analysis of vancomycin-induced red man syndrome.","volume":"12","author":"Zheng","year":"2019","journal-title":"Chin J Rational Drug Use Clin Pract"},{"key":"R4-20260119","first-page":"561","article-title":"Chinese expert consensus on clinical application of vancomycin (2011 edition).","volume":"30","author":"Weng","year":"2011","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"R5-20260119","article-title":"Opioid exposure as a potential risk factor for vancomycin-resistant enterococci colonization in the absence of antimicrobial exposure.","author":"Parvathi","year":"2023","journal-title":"Am J Infect Control"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(04)15440-8","article-title":"Migraine.","volume":"363","author":"Silberstein","year":"2004","journal-title":"Lancet"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition.","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/phar.2794","article-title":"Management of noncytotoxic extravasation injuries: a focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline.","volume":"43","author":"Stefanos","year":"2023","journal-title":"Pharmacotherapy"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:28Z","timestamp":1768849348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046545","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2025-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}